MedPath

REKAMBYS 900 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

REKAMBYS 900 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

Commercialized
Register Number

1201482002

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jan 13, 2021

Dosage Form

SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

Route: VÍA INTRAMUSCULAR

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201482002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RILPIVIRINAActive
Quantity: 300 mg/ml
Name: RILPIVIRINA

ATC CLASSIFICATION (3)

J05A
J05AG
J05AG05

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.